Identifying the BRCA1 c.-107A > T variant in Dutch patients with a tumor BRCA1 promoter hypermethylation.

de Jong, Vincent M T; Pruntel, Roelof; Steenbruggen, Tessa G; Bleeker, Fonnet E; Nederlof, Petra; Hogervorst, Frans B L; Linn, Sabine C

de Jong, Vincent M T; Pruntel, Roelof; Steenbruggen, Tessa G; Bleeker, Fonnet E; Nederlof, Petra; Hogervorst, Frans B L; Linn, Sabine C.

Afiliación

de Jong VMT; Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, Netherlands.
Pruntel R; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
Steenbruggen TG; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
Bleeker FE; Department of Clinical Genetics, The Netherlands Cancer Institute, Amsterdam, Netherlands.
Nederlof P; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
Hogervorst FBL; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
Linn SC; Department of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, Netherlands. s.linn@nki.nl.

Fam Cancer ; 22(2): 151-154, 2023 04.

Article en En | MEDLINE | ID: mdl-36112334

Asunto(s)

Neoplasias de la Mama; Neoplasias Ováricas; Femenino; Humanos; Carcinógenos; Metilación de ADN; Proteína BRCA1/genética; Genes BRCA1; Regiones Promotoras Genéticas; Neoplasias Ováricas/genética; Neoplasias Ováricas/patología; Neoplasias de la Mama/genética

Palabras clave

BRCA1; Breast cancer; Methylation

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias de la Mama Idioma: En Revista: Fam Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google